Search Results for 'ibrutinib'
ibrutinib published presentations and documents on DocSlides.
Ibrutinib for Hairy Cell Leukemia
by pasty-toler
. A Brief Update of an Ongoing Trial. Jeff Jones...
Ibrutinib : First-in Class Inhibitor of BTK
by briana-ranney
Forms a specific and irreversible bond with cyste...
Ibrutinib: Analysis of Pivotal Data
by alida-meadow
Richard R. Furman, MD. CLL Research Center. BCR-a...
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
by ellena-manuel
Pharmacist Focus on BTK Inhibitors Moderator Shil...
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
BTK Inhibitors and Cardiac Considerations in Chronic Lymphocytic Leukemia
by tawny-fly
Overview. Overview (cont). Ibrutinib. -R. elated ...
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Randomized Comparison of Ibrutinib Versus Ofatumumab in Rel
by jane-oiler
Presented By John Byrd at 2014 ASCO Annual Meetin...
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
Updates in Lymphoma From Recent Congresses
by lindy-dunigan
Therapeutic Targets in CLL. Venetoclax in Patient...
First Prospective Data on Minimal Residual Disease (MRD) Outcomes After Fixed-Duration Ibrutinib P
by mia
Ibr+Ven. ) Versus Chlorambucil Plus Obinutuzumab (...
Research To Practice ASH 2022 CLL Updates
by erica
John N. Allan. Associate Professor of Clinical Med...
